42 research outputs found
Gluon polarization in the nucleon from quasi-real photoproduction of high-pT hadron pairs
We present a determination of the gluon polarization Delta G/G in the
nucleon, based on the helicity asymmetry of quasi-real photoproduction events,
Q^2<1(GeV/c)^2, with a pair of large transverse-momentum hadrons in the final
state. The data were obtained by the COMPASS experiment at CERN using a 160 GeV
polarized muon beam scattered on a polarized 6-LiD target. The helicity
asymmetry for the selected events is = 0.002 +- 0.019(stat.) +-
0.003(syst.). From this value, we obtain in a leading-order QCD analysis Delta
G/G=0.024 +- 0.089(stat.) +- 0.057(syst.) at x_g = 0.095 and mu^2 =~ 3
(GeV}/c)^2.Comment: 10 pages, 3 figure
First Measurement of the Transverse Spin Asymmetries of the Deuteron in Semi-Inclusive Deep Inelastic Scattering
First measurements of the Collins and Sivers asymmetries of charged hadrons
produced in deep-inelastic scattering of muons on a transversely polarized
6-LiD target are presented. The data were taken in 2002 with the COMPASS
spectrometer using the muon beam of the CERN SPS at 160 GeV/c. The Collins
asymmetry turns out to be compatible with zero, as does the measured Sivers
asymmetry within the present statistical errors.Comment: 6 pages, 2 figure
The Deuteron Spin-dependent Structure Function g1d and its First Moment
We present a measurement of the deuteron spin-dependent structure function
g1d based on the data collected by the COMPASS experiment at CERN during the
years 2002-2004. The data provide an accurate evaluation for Gamma_1^d, the
first moment of g1d(x), and for the matrix element of the singlet axial
current, a0. The results of QCD fits in the next to leading order (NLO) on all
g1 deep inelastic scattering data are also presented. They provide two
solutions with the gluon spin distribution function Delta G positive or
negative, which describe the data equally well. In both cases, at Q^2 = 3
(GeV/c)^2 the first moment of Delta G is found to be of the order of 0.2 - 0.3
in absolute value.Comment: fits redone using MRST2004 instead of MRSV1998 for G(x), correlation
matrix adde
A new measurement of the Collins and Sivers asymmetries on a transversely polarised deuteron target
New high precision measurements of the Collins and Sivers asymmetries of
charged hadrons produced in deep-inelastic scattering of muons on a
transversely polarised 6LiD target are presented. The data were taken in 2003
and 2004 with the COMPASS spectrometer using the muon beam of the CERN SPS at
160 GeV/c. Both the Collins and Sivers asymmetries turn out to be compatible
with zero, within the present statistical errors, which are more than a factor
of 2 smaller than those of the published COMPASS results from the 2002 data.
The final results from the 2002, 2003 and 2004 runs are compared with naive
expectations and with existing model calculations.Comment: 40 pages, 28 figure
Measurement of the Spin Structure of the Deuteron in the DIS Region
We present a new measurement of the longitudinal spin asymmetry A_1^d and the
spin-dependent structure function g_1^d of the deuteron in the range 1 GeV^2 <
Q^2 < 100 GeV^2 and 0.004< x <0.7. The data were obtained by the COMPASS
experiment at CERN using a 160 GeV polarised muon beam and a large polarised
6-LiD target. The results are in agreement with those from previous experiments
and improve considerably the statistical accuracy in the region 0.004 < x <
0.03.Comment: 10 pages, 6 figures, subm. to PLB, revised: author list, Fig. 4,
details adde
The COMPASS Experiment at CERN
The COMPASS experiment makes use of the CERN SPS high-intensitymuon and
hadron beams for the investigation of the nucleon spin structure and the
spectroscopy of hadrons. One or more outgoing particles are detected in
coincidence with the incoming muon or hadron. A large polarized target inside a
superconducting solenoid is used for the measurements with the muon beam.
Outgoing particles are detected by a two-stage, large angle and large momentum
range spectrometer. The setup is built using several types of tracking
detectors, according to the expected incident rate, required space resolution
and the solid angle to be covered. Particle identification is achieved using a
RICH counter and both hadron and electromagnetic calorimeters. The setup has
been successfully operated from 2002 onwards using a muon beam. Data with a
hadron beam were also collected in 2004. This article describes the main
features and performances of the spectrometer in 2004; a short summary of the
2006 upgrade is also given.Comment: 84 papes, 74 figure
Search for the Phi(1860) Pentaquark at COMPASS
Narrow Xi-pi+- and Xi-bar+pi+- resonances produced by quasi-real photons have
been searched for by the COMPASS experiment at CERN. The study was stimulated
by the recent observation of an exotic baryonic state decaying into Xi-pi-, at
a mass of 1862 MeV, interpreted as a pentaquark. While the ordinary hyperon
states Xi(1530)^0 and Xi-bar(1530)^0 are clearly seen, no exotic baryon is
observed in the data taken in 2002 and 2003.Comment: 10 pages, 5 figure
An innovative approach to pharmacy management in a state correctional system
Numerous models are employed for medication distribution and pharmacy services management in correctional facilities. Since 2003, the University of Rhode Island College of Pharmacy and the Rhode Island Department of Corrections (RIDOC) have collaborated on a pharmacy management program designed to better integrate medical care, improve medication utilization, and reduce pharmaceuticals costs. The program introduced staff education, waste-reduction strategies, treatment protocols, and a responsive formulary system. RIDOC pharmaceutical expenditures grew at a rate of approximately 1.5% Per Inmate Per Year from 2003 to 2009, considerably below the annual pharmaceutical inflation rate. Analyses of projected and actual drug spending indicate that RIDOC benefited from savings of almost $5 million during this period. This innovative approach to pharmacy management addressed many pharmaceutical care issues that had challenged RIDOC while providing educational opportunities for doctor of pharmacy students in this practice setting. © NCCHC 2012
Inhibition of autophagy in EBV-positive Burkitt’s lymphoma cells enhances EBV lytic genes expression and replication
Autophagy, an important degradation system involved in maintaining cellular homeostasis, serves also to eliminate pathogens and process their fragments for presentation to the immune system. Several viruses have been shown to interact with the host autophagic machinery to suppress or make use of this cellular catabolic pathway to enhance their survival and replication. Epstein Barr virus (EBV) is a γ-herpes virus associated with a number of malignancies of epithelial and lymphoid
origin in which establishes a predominantly latent infection. EBV lytic cycle characterized by the sequential expression of immediate early
(IE), early and late antigens results in the production of infectious particles which allow the virus to spread. In this study we analyzed the
relationship between EBV and autophagy after inducing the virus productive cycle in Burkitt’s lymphoma (BL) cells. By monitoring autophagy markers and EBV lytic genes expression, we demonstrate that autophagy is enhanced in the early phases of EBV lytic activation but decreases thereafter concomitantly with increased levels of EBV lytic proteins. In a cell line defective for late antigens expression, we found an inverse correlation between EBV early antigens expression
and autophagosomes formation indicating that early after activation, the virus is able to suppress autophagy.We report that inhibition of autophagy by Bafilomycin A1 or shRNA knockdown of beclin1 gene, enhance EBV lytic genes expression as well as intracellular viral DNA and viral progeny yield. Taken together, these findings indicate that
viral replication induces an autophagic response which can inhibit the further expression of EBV early lytic products. Moreover, our findings
open the possibility to utilize pharmacological modulators of autophagy to control EBV infection and treat EBV-related lymphomas